Merck & Co Inc (NYSE:MRK) Stock News, Headlines & Updates
Merck & Co Inc Stock News from GuruFocus
- 1
- 2
- 3
- 4
- 5
Jul 13, 2025
Merck (MRK) Confirms $10B Acquisition of Verona Pharma
GuruFocus News • 8:55am
Jul 12, 2025
Merck (MRK) Announces $10 Billion Acquisition of Verona Pharma
GuruFocus News • 2:55pm
Jul 10, 2025
Merck (MRK) Gains FDA Nod for Bravecto Quantum for Canine Flea and Tick Prevention
GuruFocus News • 4:57pm
Merck (MRK) Gains FDA Approval for New Dog Flea and Tick Treatment | MRK Stock News
GuruFocus News • 4:16pm
FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health | MRK Stock News
GuruFocus News • 4:00pm
FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health
Business Wire • 4:00pm
Merck & Co (MRK) Price Target Adjusted by Morgan Stanley | MRK Stock News
GuruFocus News • 11:35am
Merck (MRK) Awaits FDA Decision on New HIV-1 Drug Application
GuruFocus News • 10:55am
Merck (MRK) Sees Price Target Adjustment Amid Market Challenges | MRK Stock News
GuruFocus News • 8:02am
Merck (MRK) Offers $10 Billion for Verona Pharma Acquisition | MRK Stock News
GuruFocus News • 6:47am
Merck (MRK) Advances HIV Drug with FDA Review of New Therapy | MRK Stock News
GuruFocus News • 6:19am
U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection |
GuruFocus News • 6:00am
U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection
Business Wire • 6:00am
Jul 09, 2025
Market Today: Merck's $10B Acquisition of Verona Pharma Boosts Biotech Sector
GuruFocus News • 4:32pm
Merck (MRK) to Acquire Verona Pharma for $10 Billion | MRK Stock News
GuruFocus News • 3:48pm
Merck & Co Inc (MRK) Stock Price Up 3.17% on Jul 9
GuruFocus News • 12:06pm
Merck (MRK) Acquires Verona Pharma in $10 Billion Deal | MRK Stock News
GuruFocus News • 11:45am
Merck (MRK) to Acquire Verona Pharma in $107 Per Share Deal | MRK Stock News
GuruFocus News • 8:17am
Merck (MRK) Stock Insights and Market Updates | MRK Stock News
GuruFocus News • 8:17am
First Look: Merck's $10B Acquisition and Bezos' Amazon Stock Sale
GuruFocus News • 7:45am
Trump Unleashes Tariff Tsunami: Copper at 50%, Pharma Faces 200% -- Markets Rattle
Khac Phu Nguyen • 6:18am
Merck & Co Inc (MRK) to Acquire Verona Pharma for $10 Billion | MRK stock news
GuruFocus News • 6:04am
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
Business Wire • 6:00am
Merck (MRK) to Acquire Verona Pharma in $10B Deal | MRK Stock News
GuruFocus News • 5:48am
MRK to Acquire Verona Pharma for $107 Per Share | MRK Stock News
GuruFocus News • 5:48am
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade |
GuruFocus News • 5:46am
Merck (MRK) Nearing $10 Billion Acquisition of Verona Pharma | MRK Stock News
GuruFocus News • 5:16am
Merck (MRK) Nears $10 Billion Acquisition of Verona Pharma (VRNA)
GuruFocus News • 12:55am
Jul 08, 2025
Merck (MRK) Responds to Tariff Threats with U.S. Expansion Plans
GuruFocus News • 1:57pm
Merck & Co Inc (MRK) Unveils New HIV Research Data at IAS 2025 | MRK stock news
GuruFocus News • 6:01am
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025 | MRK Stock News
GuruFocus News • 6:00am
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025
Business Wire • 6:00am
Jul 02, 2025
Merck (MRK) Faces Industry Turmoil Amid BIO's Rebuke of RFK Jr.
GuruFocus News • 2:56pm
Merck's Drug Slashes PAH Risk by 76%--FDA Fast-Tracks Game-Changer
Khac Phu Nguyen • 12:32pm
Merck (MRK) Seeks FDA Approval for Revised Winrevair Label
GuruFocus News • 6:56am
Merck & Co Inc (MRK) Announces FDA Priority Review for WINREVAIRâ„¢ Label Update | MRK stock news
GuruFocus News • 6:01am
FDA Grants Priority Review for WINREVAIRâ„¢ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial | MRK Stock News
GuruFocus News • 6:00am
FDA Grants Priority Review for WINREVAIRâ„¢ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
Business Wire • 6:00am
Jul 01, 2025
Merck & Co Inc (MRK) Shares Up 3.64% on Jul 1
GuruFocus News • 12:03pm
Merck & Co. (MRK) in Andrew Hill Investment Advisors 2023 Q1
GuruFocus News • 11:01am
- 1
- 2
- 3
- 4
- 5
Show
Entries
Headlines
Total 0- 1
No recent news